AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 52 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $267,000 | -15.2% | 91,057 | -23.5% | 0.00% | – |
| Q2 2018 | $315,000 | -83.7% | 119,052 | -13.4% | 0.00% | -100.0% |
| Q1 2018 | $1,935,000 | +19.2% | 137,418 | -0.5% | 0.00% | +50.0% |
| Q4 2017 | $1,624,000 | +437.7% | 138,132 | +548.4% | 0.00% | – |
| Q3 2017 | $302,000 | +21.8% | 21,302 | +20.7% | 0.00% | – |
| Q2 2017 | $248,000 | -58.6% | 17,646 | -51.4% | 0.00% | -100.0% |
| Q4 2016 | $599,000 | +64.6% | 36,300 | -34.0% | 0.00% | 0.0% |
| Q2 2016 | $364,000 | +193.5% | 55,037 | +291.1% | 0.00% | – |
| Q1 2016 | $124,000 | -68.1% | 14,072 | -54.9% | 0.00% | -100.0% |
| Q4 2015 | $389,000 | -50.6% | 31,195 | -44.3% | 0.00% | -50.0% |
| Q3 2015 | $788,000 | – | 56,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
| Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
| Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
| Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
| DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
| UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
| Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
| DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
| Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |